Home » Newsletters » BioWorld Science

BioWorld Science

May 16, 2012

View Archived Issues

NKP-2235 shows unique cytotoxicity profile and synergistic activity with other anticancer agents

Recombinant vectors targeting NY-ESO-1 assessed in phase II trials

First HSP 90-alpha-binding agent with promising antiglaucoma activity

The Arizona Biomedical Research Commission prepares novel EGFR-based peptides

Astellas Pharma reflects on accomplishments of fiscal 2011

New biomarker for measuring disease severity in patients with diabetic retinopathy

StarGen gene therapy being tested in phase I/II clinical trial

German team discloses novel voltage-gated potassium channel modulators

Ono Pharmaceutical recaps events of fourth quarter 2011

Biota Scientific Management prepares new antiviral agents

Researchers at Merck & Co. report new series of phosphodiesterase 10A inhibitors

Blood glucose-lowering agents patented by Daiichi Sankyo

Novel IL-17 production inhibitors synthesized by Japanese group

Novelos Therapeutics provides update on HOT radiotherapeutic agent

Theraclone Sciences reports topline phase I TCN-032 study data

FDA approves TG Therapeutics' IND for phase I/II ublituximab study

Celsion and Philips Healthcare resubmit IND for ThermoDox combination study

NIDA grant supports Scripps Research Institute smoking cessation research

Cardiac function improves in preclinical study of PLX cells

ACH-3102 receives FDA fast track designation for the treatment of HCV

Phase I/IIa trial begins for Aes-103 in sickle cell disease

GSK to acquire Cellzome

Innova Biosciences awarded grant to develop nanoparticle products

Phase I/II trials begins of combination therapy for advanced metastatic melanoma

Juventas opens enrollment in phase IIa study of JVS-100

Medtronic's Resolute Integrity stent receives approval in new indications in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...